Clinical significance of endocrine disorders in the development of early vascular aging in males with abdominal obesity and concomitant arterial hypertension: An observational cohort study

Background. Visceral obesity is a risk factor in the development of metabolic and endocrine disorders leading to arterial hypertension and cardiovascular complications. Their early predictors include increased vascular stiffness and early vascular aging. The current literature lacks studies into the effects of changes in testosterone, cortisol, and aldosterone levels in serum on vascular stiffness and the development of early vascular aging in patients with visceral obesity. Objective. To determine the relationship between hypercortisolemia, hyperaldosteronemia, and hypotestosteronemia and vascular stiffness and the presence of early vascular aging in male patients with visceral obesity. Methods. An observational cohort study of 78 males aged 35–45 years (mean age 38.1 ± 6.5 years) diagnosed with abdominal obesity and grade 1 arterial hypertension was conducted. The mean waist circumference ranged 105.5 ± 6.9 cm; systolic and diastolic blood pressure ranged 152.5 ± 5.0 and 92.5 ± 5.0 mm Hg, respectively. The vascular age of the studied patients (n = 78) comprised 44.1 ± 6.2 years, which was statistically higher than their passport age (р < 0.001). The studied patients were divided into subgroups according to both total testosterone (< 12.1 nmol/l in subgroup 1A (n = 49) and ≥ 12.1 nmol/L in subgroup 1B (n = 29)) and cortisol in the evening saliva portion (> 4.5 nmol/L in subgroup 2A (n = 24) and ≤ 4.5 nmol/L in subgroup 2B (n = 24)). All the patients completed the study. To assess the hormonal status, the total testosterone sex steroid-binding globulin (SSBP) and insulin in morning serum samples were investigated. Insulin resistance was assessed based on the NOMA-IR index. The concentration of total testosterone was determined by enhanced chemiluminescence (Ortho-Clinical Diagnostics, J&J); the SSBP and insulin levels were determined by delayed fluorescence. Aldosterone content was determined by radioimmunoassay; free cortisol and testosterone were measured by luminescent LIA. Free and bioavailable testosterone concentrations in serum were calculated using an online calculator (issam.ch/freetesto.htm). The cardio-ankle vascular index (CAVI) was determined using a VaSera VS-15000N device, which automatically calculated the vascular age. Statistical analysis was performed using the Statistica 10.0 Windows package (StatSoft, Inc., USA). Results. The vascular age of patients with hypogonadism was statistically significantly ( р < 0.001) higher than their passport age and the vascular age in males without hypogonadism. The CAVI and vascular age were also statistically significantly higher in males with functional hypercorticism (р < 0.001) compared with a subgroup of patients without hypercorticism. The vascular age and CAVI increased with an increase in the salivary cortisol concentration 22⁰⁰ (r = 0.5; р < 0.05) and decreased with an increase in the salivary cortisol level 9⁰⁰ (r = –0.5; р < 0.05). These parameters decreased with an increase in serum aldosterone obtained in the morning (r = –0.4; p < 0.05) and increased with an increase in serum aldosterone in the evening (r = 0.4; p < 0.05). In 23% (n = 18), an inversion of the daily rhythm of cortisol production was observed; in these patients, salivary cortisol levels of 22⁰⁰ exceeded salivary cortisol levels of 9⁰⁰. The vascular age of patients with the inversion of cortisol production (49.4 ± 4.4 years) was statistically significantly ( р < 0.001) different from that of patients with normal changes in salivary cortisol concentrations (41.9 ± 4.9 years). CAVI was also higher (р < 0.001) in males with inverted fluctuations in salivary cortisol levels (7.51 ± 0.62) compared to those with normal diurnal rhythm (6.45 ± 0.69). The results of aldosterone evaluation revealed that 17% of the patients (n = 13) had higher aldosterone levels in the evening serum portion compared to the morning serum portion. In these patients, the vascular age (45.8 ± 5.1 years) was higher ( р < 0.001) than that in males with normal physiologic changes in aldosterone levels (41.6 ± 5.7 years). A similar pattern was observed when comparing vascular stiffness indices. Thus, the CAVI in men with inverted changes in aldosterone concentration (6.9 ± 0.8) was significantly higher ( р < 0.001), compared to that in men with physiological changes in blood aldosterone levels (6.4 ± 0.8). Conclusion. Endocrinologic disorders in male patients with visceral obesity and concomitant arterial hypertension (functional hypogonadism, functional hypercorticism, inverted daily rhythms of cortisol and aldosterone production) contribute to the development of early vascular aging by increasing vascular stiffness.

1. Balanova YuA, Shalnova SA, Deev AD, Imaeva AE, Kontsevaya AV, Muromtseva GA, Kapustina AV, Evstifeeva SE, Drapkina ОМ. Obesity in russian population — prevalence and association with the non-communicable diseases risk factors. Russian Journal of Cardiology. 2018;6:123-130 (In Russ.). https://doi.org/10.15829/1560-4071-2018-6-123-130

2. Reyes-Farias M, Fos-Domenech J, Serra D, Herrero L, Sánchez-Infantes D. White adipose tissue dysfunction in obesity and aging. Biochem Pharmacol. 2021;192:114723. https://doi.org/10.1016/j.bcp.2021.114723

3. Wang ZY, Li BC, Xing JJ, Liu SY, Zhang TT, Xu AM, Wang ZJ. Associations of waist circumference with sex steroid hormones among 4031 USA children and adolescents. Asian J Androl. 2023;25(4):505-511. https://doi.org/10.4103/aja202284

4. Khripun IA, Vorobyev SV. Hypogonadism as type 2 diabetes mellitus comorbidity. FOCUS Endocrinology. 2020;1:16-20 (In Russ.). https://doi.org/10.47407/ef2020.1.1.0002

5. Gencer B, Bonomi M, Adorni MP, Sirtori CR, Mach F, Ruscica M. Cardiovascular risk and testosterone — from subclinical atherosclerosis to lipoprotein function to heart failure. Rev Endocr Metab Disord. 2021;22(2):257-274. https://doi.org/10.1007/s11154-021-09628-2

6. Abulizi A, Camporez JP, Jurczak MJ, H0yer KF, Zhang D, Cline GW, Samuel VT, Shulman GI, Vatner DF. Adipose glucocorticoid action influences whole-body metabolism via modulation of hepatic insulin action. FASEB J. 2019;33(7):8174-8185. https://doi.org/10.1096/fj.201802706R

7. Armani A, Marzolla V, Fabbri A, Caprio M. Cellular mechanisms of MR regulation of adipose tissue physiology and pathophysiology. J Mol Endocrinol. 2015;55(2):R1-10. https://doi.org/10.1530/JME-15-0122

8. Jia G, Aroor AR, Hill MA, Sowers JR. Role of Renin-Angiotensin-Al-dosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness. Hypertension. 2018;72(3):537-548. https://doi.org/10.1161/HYPERTENSIONAHA.118.11065

9. Lunenfeld B, Mskhalaya G, Zitzmann M, Arver S, Kalinchen-ko S, Tishova Y, Morgentaler A. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male. 2015;18(1):5-15. https://doi.org/10.3109/13685538.2015.1004049

10. Jenkins HN, Rivera-Gonzalez O, Gibert Y, Speed JS. Endothelin-1 in the pathophysiology of obesity and insulin resistance. Obes Rev. 2020;21(12):e13086. https://doi.org/10.1111/obr.13086

11. Mayorov AYu, Urbanova KA, Galstyan GR. Methods for guantificative assessment of insulin resistance. Obesity and metabolism. 2009;6(2):19-23 (In Russ.). https://doi.org/10.14341/2071-8713-5313

12. Goma TV, Tsyrenova AA. Assessment of the relationship of vascular age, determined by volumetric sphygmography, atherogenic plasma index with the main clinical, laboratory and hemodynamic parameters in hypertension. Atherosclerosis. 2023;19(3):198-200. https://doi.org/10.52727/2078-256X-2023-19-3-198-200

13. Laurent S, Boutouyrie P, Cunha PG, Lacolley P, Nilsson PM. Concept of Extremes in Vascular Aging. Hypertension. 2019;74(2):218-228. http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.12655

14. Nedogoda SV, Salasyuk AS, Barykina IN, Lutova VO, Popova EA. Early vascular aging in patients with metabolic syndrome: features of the course and diagnosis. South Russian Journal of Therapeutic Practice. 2021;2(1):50-62 (In Russ.). https://doi.org/10.21886/2712-8156-2021-2-1-50-62

15. Zairova AR, Rogoza AN, Oshchepkova EV, Yarovaya EB, Kutsenko VA, Shalnova SA, Trubacheva IA, Kaveshnikov VS, Serebryakova VN, Boytsov SA. Contribution of cardioankle vascular index to prediction of cardiovascular events in the adult urban population: data from the ESSE-RF study (Tomsk). Cardiovascular Therapy and Prevention. 2021;20(5):2967 (In Russ.). https://doi.org/10.15829/1728-8800-2021-2967

16. Verner VA, Mel'nik MV, Knjazeva S.A. Cardio-ankle vascular index (CAVI) in diagnostics, risk and severity evaluation of magistral vessels lesion in patients with cardio-vascular diseases and type 2 diabetes. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(1):87-93 (In Russ.). https://doi.org/10.26442/00403660.2021.01.200599

17. Dedov II, Mokrysheva NG, Melnichenko GA, Rozhivanov RV., Ka-malov AA, Mkrtumyan АМ, Khalimov YuSh, Vorokhobina NV. Draft of Russian Clinical Practice Guidelines “Male hypogonadism”. Obesity and Metabolism. 2021;18(4):496-507 (In Russ.). https://doi.org/10.14341/omet12817

18. Bianchi VE. The Anti-Inflammatory Effects of Testosterone. J Endocr Soc. 2018;3(1):91-107. https://doi.org/10.1210/js.2018-00186

19. Inoue K, Horwich T, Bhatnagar R, Bhatt K, Goldwater D, Seeman T, Watson KE. Urinary Stress Hormones, Hypertension, and Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis. Hypertension. 2021;78(5):1640-1647. https://doi.org/10.1161/HYPERTENSIONAHA.121.17618

20. Belaya ZhE, Malygina AA, Grebennikova TA, Il'yin AV, Rozhinskaya LYa, Fadeev VV, Melnichenko GA, Dedov II. Diagnostic value of salivary cortisol in 1-mg dexamethasone suppression test. Obesity and metabolism. 2020;17(1):13-21 (In Russ.). https://doi.org/10.14341/omet10117

21. Anderson AJ, Andrew R, Homer NZM, Hughes KA, Boyle LD, Nixon M, Karpe F, Stimson RH, Walker BR. Effects of Obesity and Insulin on Tissue-Specific Recycling Between Cortisol and Cortisone in Men. J Clin Endocrinol Metab. 2021;106(3):e1206-e1220. https://doi.org/10.1210/clinem/dgaa896

22. Kuznetsova EA, Adamchik AS, Goncharov NP, Katsi GV. Diagnostic value of daily fluctuations in the free form of testosterone and cortisol in men with obesity and metabolic syndrome under the age of 50 years. Andrology and Genital Surgery. 2016;17(1):28-33 (In Russ.). https://doi.org/10.17650/2070-9781-2016-17-1-28-33

23. Kalsbeek A, Su Y, Fliers E, Fleur S. The Hypothalamic-Pituitary-Adrenal Axis: Circadian Dysregulation and Obesity. In Russell J, Shipston M., editors. Neuroendocrinology of Stress. 2015;219-244. https://doi.org/10.1002/9781118921692.ch10

24. Goncharov P.P. Aldosterone and cardiovascular function (to the 50th anniversary of the discovery of aldosterone). Problems of Endocrinology. 2004;50(6):29-32 (In Russ.). https://doi.org/10.14341/probl11621

25. Jia G, Aroor AR, Sowers JR. The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall. Cardiovasc Res. 2017;113(9):1055-1063. https://doi.org/10.1093/cvr/cvx097

26. Kireeva VV, Lepekhova SA, Mansurova LN, Dugarova SC. Epigenetic and molecular and genetic aspects of obesity as a risk factor of cardiovascular catastrophes. Eurasian Union Scientists. 2020;5(7(76)):39-44 (In Russ.). https://doi.org/10.31618/esu.2413-9335.2020.5.76.926

27. Ding YN, Tang X, Chen HZ, Liu DP. Epigenetic Regulation of Vascular Aging and Age-Related Vascular Diseases. Adv Exp Med Biol. 2018;1086:55-75. https://doi.org/10.1007/978-981-13-1117-8_4

28. Min SH, Kim SH, Jeong IK, Cho HC, Jeong JO, Lee JH, Kang HJ, Kim HS, Park KS, Lim S. Independent Association of Serum Aldosterone Level with Metabolic Syndrome and Insulin Resistance in Korean Adults. Korean Circ J. 2018;48(3):198-208. http://dx.doi.org/10.4070/kcj.2017.0200

29. Keevil BG, Adaway J. Assessment of free testosterone concentration. J Steroid Biochem Mol Biol. 2019;190:207-211. http://dx.doi.org/10.1016/j.jsbmb.2019.04.008